{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:07:13Z","timestamp":1793995633276,"version":"4.8.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170865"],"award-info":[{"award-number":["82170865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370856"],"award-info":[{"award-number":["82370856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101029"],"award-info":[{"award-number":["32101029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QB164"],"award-info":[{"award-number":["ZR2020QB164"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211365"],"award-info":[{"award-number":["tsqn202211365"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202203060805"],"award-info":[{"award-number":["202203060805"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202203060917"],"award-info":[{"award-number":["202203060917"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gendis.2024.101481","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T12:14:21Z","timestamp":1733314461000},"page":"101481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies"],"prefix":"10.1016","volume":"12","author":[{"given":"Yixin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9224-9465","authenticated-orcid":false,"given":"Kexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-8465","authenticated-orcid":false,"given":"Ningning","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-8763","authenticated-orcid":false,"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxia","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-2823","authenticated-orcid":false,"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0757.2011.00440.x","article-title":"Principles of endocrinology","volume":"61","author":"Leblebicioglu","year":"2013","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.gendis.2024.101481_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114959","article-title":"Recent advances in endocrine organoids for therapeutic application","volume":"199","author":"Jeon","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.gendis.2024.101481_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2022.105216","article-title":"Evolution of hormone-phenotype couplings and hormone-genome interactions","volume":"144","author":"Cox","year":"2022","journal-title":"Horm Behav"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/biomedicines12010221","article-title":"Microbiota implications in endocrine-related diseases: from development to novel therapeutic approaches","volume":"12","author":"Clemente-Su\u00e1rez","year":"2024","journal-title":"Biomedicines"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2024.101481_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbiomolbio.2015.02.012","article-title":"Nuclear receptors in transgenerational epigenetic inheritance","volume":"118","author":"Ozgyin","year":"2015","journal-title":"Prog Biophys Mol Biol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/cells8060602","article-title":"The role of nuclear receptors in prostate cancer","volume":"8","author":"Shiota","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.11613\/BM.2014.035","article-title":"The many faces of estrogen signaling","volume":"24","author":"Vrta\u010dnik","year":"2014","journal-title":"Biochem Med"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/endrev\/bnab014","article-title":"How protein methylation regulates steroid receptor function","volume":"43","author":"Malbeteau","year":"2022","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1475-1313.2010.00735.x","article-title":"Epigenetic control of expression of the human L- and M- pigment genes","volume":"30","author":"Deeb","year":"2010","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.mam.2012.07.018","article-title":"Epigenetics: the link between nature and nurture","volume":"34","author":"Tammen","year":"2013","journal-title":"Mol Aspect Med"},{"issue":"9","key":"10.1016\/j.gendis.2024.101481_bib11","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/ijms21093177","article-title":"Estradiol-induced epigenetically mediated mechanisms and regulation of gene expression","volume":"21","author":"Kov\u00e1cs","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016709","article-title":"Signaling by nuclear receptors","volume":"5","author":"Sever","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.gendis.2024.101481_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104680","article-title":"Hormone-epigenome interactions in behavioural regulation","volume":"118","author":"Baumbach","year":"2020","journal-title":"Horm Behav"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib14","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/s41467-021-26277-w","article-title":"Histone H4 lysine 16 acetylation controls central carbon metabolism and diet-induced obesity in mice","volume":"12","author":"Pessoa","year":"2021","journal-title":"Nat Commun"},{"issue":"Suppl_10","key":"10.1016\/j.gendis.2024.101481_bib15","doi-asserted-by":"crossref","first-page":"x3","DOI":"10.1093\/annonc\/mdz281","article-title":"Overview of the relevance of PI3K pathway in HR-positive breast cancer","volume":"30","author":"Vasan","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2024.101481_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","article-title":"DNA methyltransferases and their roles in tumorigenesis","volume":"5","author":"Zhang","year":"2017","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2006.09.002","article-title":"Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours","volume":"43","author":"Butcher","year":"2007","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.gendis.2024.101481_bib19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7150\/ijms.27333","article-title":"Influence of DNA methylation on the expression of OPG\/RANKL in primary osteoporosis","volume":"15","author":"Wang","year":"2018","journal-title":"Int J Med Sci"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41581-021-00399-2","article-title":"Kidney and epigenetic mechanisms of salt-sensitive hypertension","volume":"17","author":"Kawarazaki","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib21","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/en.2005-1119","article-title":"Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring","volume":"147","author":"Champagne","year":"2006","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.gendis.2024.101481_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/tpj.2015.26","article-title":"The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness","volume":"16","author":"Ouni","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020065","article-title":"DNA methylation supports intrinsic epigenetic memory in mammalian cells","volume":"2","author":"Feng","year":"2006","journal-title":"PLoS Genet"},{"issue":"18","key":"10.1016\/j.gendis.2024.101481_bib25","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/sj.onc.1210041","article-title":"Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer","volume":"26","author":"Zhong","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/epi.10.75","article-title":"Epigenetic regulation by nuclear receptors","volume":"3","author":"Green","year":"2011","journal-title":"Epigenomics"},{"issue":"13","key":"10.1016\/j.gendis.2024.101481_bib27","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1073\/pnas.97.13.7202","article-title":"The histone deacetylase-3 complex contains nuclear receptor corepressors","volume":"97","author":"Wen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.molcel.2003.08.008","article-title":"N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso","volume":"12","author":"Yoon","year":"2003","journal-title":"Mol Cell"},{"issue":"14","key":"10.1016\/j.gendis.2024.101481_bib29","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/MCB.00083-07","article-title":"Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters","volume":"27","author":"Kininis","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"30","key":"10.1016\/j.gendis.2024.101481_bib30","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1038\/sj.onc.1210229","article-title":"Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis","volume":"26","author":"Takayama","year":"2007","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.gendis.2024.101481_bib31","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1101\/gad.1907110","article-title":"Propagation of adipogenic signals through an epigenomic transition state","volume":"24","author":"Steger","year":"2010","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bcp.2010.03.013","article-title":"Troglitazone is an estrogen-related receptor alpha and gamma inverse agonist","volume":"80","author":"Wang","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1385\/MN:30:3:307","article-title":"Nuclear receptor coregulators are new players in nervous system development and function","volume":"30","author":"Nishihara","year":"2004","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009853","article-title":"Distinct and histone-specific modifications mediate positive versus negative transcriptional regulation of TSHalpha promoter","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/antiox12030641","article-title":"The transcription factor NRF2 has epigenetic regulatory functions modulating HDACs, DNMTs, and miRNA biogenesis","volume":"12","author":"Silva-Llanes","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.gendis.2024.101481_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fbioe.2019.00365","article-title":"Prediction of circRNAs based on the DNA methylation-mediated feature sponge function in breast cancer","volume":"7","author":"Gu","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1039\/C5MB00513B","article-title":"MicroRNAs regulate KDM5 histone demethylases in breast cancer cells","volume":"12","author":"Denis","year":"2016","journal-title":"Mol Biosyst"},{"issue":"14","key":"10.1016\/j.gendis.2024.101481_bib39","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1158\/0008-5472.CAN-15-3339","article-title":"Histone deacetylase inhibition in prostate cancer triggers miR-320-mediated suppression of the androgen receptor","volume":"76","author":"Sato","year":"2016","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib40","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.gendis.2024.101481_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/2159-8290.CD-15-0921","article-title":"LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern","volume":"6","author":"Sun","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.gendis.2024.101481_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103399","article-title":"Pan-cancer characterization of long non-coding RNA and DNA methylation mediated transcriptional dysregulation","volume":"68","author":"Yang","year":"2021","journal-title":"EBioMedicine"},{"issue":"40","key":"10.1016\/j.gendis.2024.101481_bib43","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/dgd.12537","article-title":"MicroRNA-29b regulates DNA methylation by targeting Dnmt3a\/3b and Tet1\/2\/3 in porcine early embryo development","volume":"60","author":"Zhang","year":"2018","journal-title":"Dev Growth Differ"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib45","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1038\/s41467-021-24302-6","article-title":"The long non-coding RNA \u03b2Faar regulates islet \u03b2-cell function and survival during obesity in mice","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.gendis.2024.101481_bib46","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/genes11111336","article-title":"DNMTs and impact of CpG content, transcription factors, consensus motifs, lncRNAs, and histone marks on DNA methylation","volume":"11","author":"Loaeza-Loaeza","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.gendis.2024.101481_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.gendis.2024.101481_bib48","doi-asserted-by":"crossref","DOI":"10.1017\/S003358351700004X","article-title":"Chromatin-remodeling for transcription","volume":"50","author":"Lorch","year":"2017","journal-title":"Q Rev Biophys"},{"issue":"19","key":"10.1016\/j.gendis.2024.101481_bib49","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1016\/j.cell.2023.08.001","article-title":"Chromatin remodeling of histone H3 variants by DDM1 underlies epigenetic inheritance of DNA methylation","volume":"186","author":"Lee","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.mce.2013.04.026","article-title":"Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling","volume":"382","author":"Magnani","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.gendis.2024.101481_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1877-1173(09)87006-3","article-title":"Chromatin remodeling and nuclear receptor signaling","volume":"87","author":"Buranapramest","year":"2009","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"7057","key":"10.1016\/j.gendis.2024.101481_bib52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature04020","article-title":"LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription","volume":"437","author":"Metzger","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ncb1546","article-title":"Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression","volume":"9","author":"Wissmann","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","article-title":"ER beta: identification and characterization of a novel human estrogen receptor","volume":"392","author":"Mosselman","year":"1996","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13277-012-0343-1","article-title":"The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women","volume":"33","author":"Prabhu","year":"2012","journal-title":"Tumor Biol"},{"issue":"7","key":"10.1016\/j.gendis.2024.101481_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040466","article-title":"Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer","volume":"7","author":"Stone","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1158\/1541-7786.MCR-16-0283","article-title":"A new role for ER\u03b1: silencing via DNA methylation of basal, stem cell, and EMT genes","volume":"15","author":"Ariazi","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib58","first-page":"128","article-title":"Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis","volume":"4","author":"Garcia-Recio","year":"2023","journal-title":"Nat Can (Ott)"},{"issue":"7","key":"10.1016\/j.gendis.2024.101481_bib59","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1523\/JNEUROSCI.5819-11.2012","article-title":"Hippocampal histone acetylation regulates object recognition and the estradiol-induced enhancement of object recognition","volume":"32","author":"Zhao","year":"2012","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib60","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4161\/epi.27688","article-title":"Effect of estrogen receptor \u03b1 binding on functional DNA methylation in breast cancer","volume":"9","author":"Ung","year":"2014","journal-title":"Epigenetics"},{"issue":"11","key":"10.1016\/j.gendis.2024.101481_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau6986","article-title":"TET2 coactivates gene expression through demethylation of enhancers","volume":"4","author":"Wang","year":"2018","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib62","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s12032-011-0107-6","article-title":"Clinical implications of ER\u03b2 methylation on sporadic breast cancers in Chinese women","volume":"29","author":"Zhao","year":"2012","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib63","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ccell.2017.04.010","article-title":"Tackling resistance to PI3K inhibition by targeting the epigenome","volume":"31","author":"Koren","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.taap.2007.05.019","article-title":"Corepressors of agonist-bound nuclear receptors","volume":"223","author":"Gurevich","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.gendis.2024.101481_bib65","article-title":"GLP-1-induced AMPK activation inhibits PARP-1 and promotes LXR-mediated ABCA1 expression to protect pancreatic \u03b2-cells against cholesterol-induced toxicity through cholesterol efflux","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"39","key":"10.1016\/j.gendis.2024.101481_bib66","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1038\/s41388-018-0312-2","article-title":"TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers","volume":"37","author":"Serandour","year":"2018","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.molcel.2017.07.026","article-title":"Structural and functional impacts of ER coactivator sequential recruitment","volume":"67","author":"Yi","year":"2017","journal-title":"Mol Cell"},{"issue":"23","key":"10.1016\/j.gendis.2024.101481_bib68","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1038\/emboj.2011.368","article-title":"Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer","volume":"30","author":"Zwart","year":"2011","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.gendis.2024.101481_bib69","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.chembiol.2023.07.005","article-title":"Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A\/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer","volume":"30","author":"Sharma","year":"2023","journal-title":"Cell Chem Biol"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112821","article-title":"High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer","volume":"42","author":"Fu","year":"2023","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12964-022-01029-5","article-title":"GRHL2-controlled gene expression networks in luminal breast cancer","volume":"21","author":"Wang","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib72","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.celrep.2019.09.032","article-title":"The lineage determining factor GRHL2 collaborates with FOXA1 to establish a targetable pathway in endocrine therapy-resistant breast cancer","volume":"29","author":"Cocce","year":"2019","journal-title":"Cell Rep"},{"issue":"23","key":"10.1016\/j.gendis.2024.101481_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz7249","article-title":"Estrogen induces dynamic ER\u03b1 and RING1B recruitment to control gene and enhancer activities in luminal breast cancer","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci Adv"},{"issue":"5992","key":"10.1016\/j.gendis.2024.101481_bib74","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167271","article-title":"Cryptic lncRNA-encoded ORFs: a hidden source of regulatory proteins","volume":"133","author":"Dutta","year":"2023","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159940","article-title":"CRISPR\/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer","volume":"133","author":"Zheng","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gendis.2024.101481_bib77","first-page":"825","article-title":"The emerging roles of exosomal miRNAs in breast cancer progression and potential clinical applications","volume":"15","author":"Li","year":"2023","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib78","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1210\/jc.2007-0494","article-title":"Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis","volume":"92","author":"Xue","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1933719113497267","article-title":"Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications","volume":"21","author":"Monteiro","year":"2014","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004158","article-title":"Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis","volume":"10","author":"Dyson","year":"2014","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib81","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1933719118756751","article-title":"The essential role of GATA6 in the activation of estrogen synthesis in endometriosis","volume":"26","author":"Bernardi","year":"2019","journal-title":"Reprod Sci"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib82","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/me.2013-1421","article-title":"ER\u03b2- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis","volume":"28","author":"Monsivais","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"11","key":"10.1016\/j.gendis.2024.101481_bib83","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1093\/humrep\/dew223","article-title":"miR-196a overexpression activates the MEK\/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis","volume":"31","author":"Zhou","year":"2016","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib84","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.febslet.2010.02.024","article-title":"The protein encoded by the functional steroid receptor RNA activator is a new modulator of ER alpha transcriptional activity","volume":"584","author":"Chooniedass-Kothari","year":"2010","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.gendis.2024.101481_bib85","doi-asserted-by":"crossref","first-page":"E224","DOI":"10.1210\/jc.2010-0154","article-title":"A Role for the orphan nuclear receptor estrogen-related receptor alpha in endometrial stromal cell decidualization and expression of genes implicated in energy metabolism","volume":"95","author":"Bombail","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"7801","key":"10.1016\/j.gendis.2024.101481_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","article-title":"A genomic and epigenomic atlas of prostate cancer in Asian populations","volume":"580","author":"Li","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41588-020-0664-8","article-title":"Prostate cancer reactivates developmental epigenomic programs during metastatic progression","volume":"52","author":"Pomerantz","year":"2020","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.gendis.2024.101481_bib88","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41588-024-01893-6","article-title":"NSD2 is a requisite subunit of the AR\/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis","volume":"56","author":"Parolia","year":"2024","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib89","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.2013.369","article-title":"Circulating microRNAs predict biochemical recurrence in prostate cancer patients","volume":"109","author":"Selth","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108585","article-title":"Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer","volume":"34","author":"Fernandes","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2024.101481_bib91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.dnarep.2016.05.031","article-title":"TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis","volume":"43","author":"Mahfoudhi","year":"2016","journal-title":"DNA Repair"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib92","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/ijms18020473","article-title":"Current insights into long non-coding RNAs (LncRNAs) in prostate cancer","volume":"18","author":"Smolle","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.gendis.2024.101481_bib93","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14737159.2021.1996227","article-title":"Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: Racial, ethnic, and geographical considerations","volume":"21","author":"Morgan","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","article-title":"LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer","volume":"13","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.gendis.2024.101481_bib95","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.urolonc.2011.11.030","article-title":"The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor","volume":"31","author":"Cui","year":"2013","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib96","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/ptr.8097","article-title":"The microRNA-193a-5p induced ROS production and disturbed colocalization between STAT3 and androgen receptor play critical roles in cornin induced apoptosis","volume":"38","author":"Choi","year":"2024","journal-title":"Phytother Res"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib97","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41588-018-0120-1","article-title":"Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression","volume":"50","author":"Zhang","year":"2018","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib98","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2024.101481_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.812077","article-title":"Insights into the role of epigenetic factors determining the estrogen response in estrogen-positive ovarian cancer and prospects of combining epi-drugs with endocrine therapy","volume":"13","author":"Sarwar","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/0008-5472.CAN-23-1362","article-title":"Cell state of origin impacts development of distinct endometriosis-related ovarian carcinoma histotypes","volume":"84","author":"Beddows","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2024.101481_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216383","article-title":"Pharmacological inhibition of KDM1A\/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer","volume":"575","author":"Venkata","year":"2023","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib102","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/cas.13920","article-title":"E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness","volume":"110","author":"Cheng","year":"2019","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib103","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/ol.2020.12014","article-title":"The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells","volume":"20","author":"Kojima","year":"2020","journal-title":"Oncol Lett"},{"issue":"20","key":"10.1016\/j.gendis.2024.101481_bib104","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.jmb.2014.02.019","article-title":"Structural insights into estrogen receptor \u03b1 methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation","volume":"426","author":"Jiang","year":"2014","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2249.2012.04646.x","article-title":"Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease","volume":"170","author":"Arakawa","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib106","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1089\/thy.2016.0576","article-title":"Changes in the DNA methylation and hydroxymethylation status of the intercellular adhesion molecule 1 gene promoter in thyrocytes from autoimmune thyroiditis patients","volume":"27","author":"Liu","year":"2017","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.gendis.2024.101481_bib107","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1210\/jc.2007-0812","article-title":"Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors","volume":"92","author":"Joseph","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.gendis.2024.101481_bib108","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"34","key":"10.1016\/j.gendis.2024.101481_bib109","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1073\/pnas.1408821111","article-title":"Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity","volume":"111","author":"Stefan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00125-007-0916-5","article-title":"Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion","volume":"51","author":"Ling","year":"2008","journal-title":"Diabetologia"},{"issue":"7239","key":"10.1016\/j.gendis.2024.101481_bib111","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nature07777","article-title":"Role of Jhdm2a in regulating metabolic gene expression and obesity resistance","volume":"458","author":"Tateishi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2024.101481_bib112","article-title":"Methylation status of vitamin D receptor gene promoter in benign and malignant adrenal tumors","volume":"2015","author":"Pilon","year":"2015","journal-title":"Internet J Endocrinol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib113","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2018.04.013","article-title":"Vitamin D switches BAF complexes to protect \u03b2 cells","volume":"173","author":"Wei","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2024.101481_bib114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cbpb.2014.03.006","article-title":"DNA methylation of pituitary growth hormone is involved in male growth superiority of Nile tilapia (Oreochromis niloticus)","volume":"171","author":"Zhong","year":"2014","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"11","key":"10.1016\/j.gendis.2024.101481_bib115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tem.2019.07.003","article-title":"Epigenetic mechanisms of the glucocorticoid receptor","volume":"30","author":"Bartlett","year":"2019","journal-title":"Trends Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib116","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1152\/ajpregu.00413.2009","article-title":"The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction","volume":"298","author":"van Straten","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib117","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1038\/s41467-021-26421-6","article-title":"Pparg signaling controls bladder cancer subtype and immune exclusion","volume":"12","author":"Tate","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2024.101481_bib118","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2022.06.247","article-title":"Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling","volume":"189","author":"Liu","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"42","key":"10.1016\/j.gendis.2024.101481_bib119","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303774120","article-title":"Loss of PPAR\u03b3 activity characterizes early protumorigenic stromal reprogramming and dictates the therapeutic window of opportunity","volume":"120","author":"Caruso","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib120","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1038\/s41467-024-50678-2","article-title":"Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer","volume":"15","author":"Plumber","year":"2024","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.gendis.2024.101481_bib121","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-17-1701","article-title":"Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer","volume":"77","author":"Goldstein","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib122","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41523-022-00470-6","article-title":"ER\u03b1-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance","volume":"8","author":"Strillacci","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"9","key":"10.1016\/j.gendis.2024.101481_bib123","first-page":"3632","article-title":"Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex","volume":"61","author":"Liu","year":"2001","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib124","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jnci\/95.5.353","article-title":"Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2\/neu in tamoxifen resistance in breast cancer","volume":"95","author":"Osborne","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 10","key":"10.1016\/j.gendis.2024.101481_bib125","doi-asserted-by":"crossref","first-page":"x12","DOI":"10.1093\/annonc\/mdz381","article-title":"Efficacy of PI3K inhibitors in advanced breast cancer","volume":"30","author":"Verret","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib126","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.celrep.2019.02.111","article-title":"PI3K inhibition activates SGK1 via a feedback loop to promote chromatin-based regulation of ER-dependent gene expression","volume":"27","author":"Toska","year":"2019","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib127","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/14656566.2021.1873952","article-title":"Alpelisib for the treatment of PIK3CA-mutated, hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"22","author":"Leenhardt","year":"2021","journal-title":"Expet Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114174","article-title":"Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer","volume":"43","author":"Blawski","year":"2024","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib129","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/1871520614666140418144610","article-title":"Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment","volume":"14","author":"Oronsky","year":"2014","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.gendis.2024.101481_bib130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.breast.2018.12.001","article-title":"The role of histone deacetylase inhibitors in metastatic breast cancer","volume":"43","author":"Zucchetti","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.gendis.2024.101481_bib131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2020.12.004","article-title":"The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives","volume":"82","author":"Sukocheva","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib132","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.clbc.2016.05.014","article-title":"Prognostic impact of discordance in hormone receptor status between primary and recurrent sites in patients with recurrent breast cancer","volume":"16","author":"Shiino","year":"2016","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib133","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41594-023-01181-7","article-title":"The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer","volume":"31","author":"Achinger-Kawecka","year":"2024","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"10.1016\/j.gendis.2024.101481_bib134","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/bjc.2011.156","article-title":"A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer","volume":"104","author":"Munster","year":"2011","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.gendis.2024.101481_bib135","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.gendis.2024.101481_bib136","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1158\/0008-5472.CAN-21-3186","article-title":"A distinct chromatin state drives therapeutic resistance in invasive lobular breast cancer","volume":"82","author":"Nardone","year":"2022","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2024.101481_bib137","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2159-8290.CD-24-0282","article-title":"Epigenetic control of cancer cell dormancy and awakening in endocrine therapy resistance","volume":"14","author":"Llinas-Bertran","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.gendis.2024.101481_bib138","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1038\/ncomms8758","article-title":"DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer","volume":"6","author":"Stone","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib139","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-022-28691-0","article-title":"Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib140","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.annonc.2024.04.013","article-title":"Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+ HER2\u2212 advanced breast cancer: Final overall survival results of MONARCH 3","volume":"35","author":"Goetz","year":"2024","journal-title":"Ann Oncol"},{"issue":"22","key":"10.1016\/j.gendis.2024.101481_bib141","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib142","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13058-019-1227-8","article-title":"Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4\/6 inhibitors against estrogen receptor-positive breast cancers","volume":"21","author":"Viswanadhapalli","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"6596","key":"10.1016\/j.gendis.2024.101481_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.gendis.2024.101481_bib144","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/er.2007-0019","article-title":"Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex","volume":"28","author":"Heemers","year":"2007","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/jm4012802","article-title":"Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities","volume":"57","author":"Rotili","year":"2014","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.gendis.2024.101481_bib146","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41591-018-0158-8","article-title":"Transcriptional addiction in cancer cells is mediated by YAP\/TAZ through BRD4","volume":"24","author":"Zanconato","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib147","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1535-7163.MCT-22-0479","article-title":"Glucocorticoid receptor (GR) activation is associated with increased cAMP\/PKA signaling in castration-resistant prostate cancer","volume":"23","author":"Bennett","year":"2024","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.gendis.2024.101481_bib148","first-page":"341","article-title":"Epigenetics in prostate cancer treatment","volume":"5","author":"Jones","year":"2021","journal-title":"J Transl Genet Genom"},{"issue":"25","key":"10.1016\/j.gendis.2024.101481_bib149","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1074\/jbc.RA119.008152","article-title":"Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"294","author":"Bai","year":"2019","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ccell.2020.05.022","article-title":"SETD2 restricts prostate cancer metastasis by integrating EZH2 and AMPK signaling pathways","volume":"38","author":"Yuan","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib151","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1535-7163.MCT-18-0432","article-title":"Hsp70 binds to the androgen receptor N-terminal domain and modulates the receptor function in prostate cancer cells","volume":"18","author":"Dong","year":"2019","journal-title":"Mol Cancer Therapeut"},{"issue":"7406","key":"10.1016\/j.gendis.2024.101481_bib152","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2024.101481_bib153","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/2159-8290.CD-23-0539","article-title":"ZNF397 deficiency triggers TET2-driven lineage plasticity and AR-targeted therapy resistance in prostate cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Cancer Discov"},{"issue":"13","key":"10.1016\/j.gendis.2024.101481_bib154","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.3390\/cancers13133325","article-title":"Chromatin and epigenetic dysregulation of prostate cancer development, progression, and therapeutic response","volume":"13","author":"Kukkonen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2024.101481_bib155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2015.03.023","article-title":"Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells","volume":"409","author":"Arosh","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib156","first-page":"1923","article-title":"Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol","volume":"130","author":"Bergman","year":"1992","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.gendis.2024.101481_bib157","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87748","article-title":"Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity","volume":"1","author":"Wang","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.gendis.2024.101481_bib158","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10555-018-9767-4","article-title":"Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review","volume":"37","author":"Sheng","year":"2018","journal-title":"Cancer Metastasis Rev"},{"issue":"7\u20138","key":"10.1016\/j.gendis.2024.101481_bib159","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.biocel.2007.02.009","article-title":"MS-275, a potent orally available inhibitor of histone deacetylases: the development of an anticancer agent","volume":"39","author":"Hess-Stumpp","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12834","article-title":"Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt\/\u03b2-catenin signalling pathway via DNA methylation","volume":"53","author":"Li","year":"2020","journal-title":"Cell Prolif"},{"issue":"40","key":"10.1016\/j.gendis.2024.101481_bib161","doi-asserted-by":"crossref","first-page":"28783","DOI":"10.1074\/jbc.M113.489732","article-title":"Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation","volume":"288","author":"Dudakovic","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.gendis.2024.101481_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101621","article-title":"The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor","volume":"298","author":"Peng","year":"2022","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.gendis.2024.101481_bib163","doi-asserted-by":"crossref","first-page":"a019497","DOI":"10.1101\/cshperspect.a019497","article-title":"Epigenetics and human disease","volume":"8","author":"Zoghbi","year":"2016","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.gendis.2024.101481_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.946811","article-title":"Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: fundamentals and beyond","volume":"13","author":"Feng","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101481_bib165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.gendis.2024.101481_bib166","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semcancer.2020.12.006","article-title":"Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: a clinical update","volume":"83","author":"Mondal","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101481_bib167","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/epi.11.99","article-title":"Epigenomic deregulation in the immune system","volume":"3","author":"Rodriguez-Cortez","year":"2011","journal-title":"Epigenomics"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224002782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224002782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:19:50Z","timestamp":1778872790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304224002782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":167,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2352304224002782"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101481","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101481"}}